Monday, August 23, 2010

Study: Drugs Protect Monkeys From Ebola

Scientists developing a drug against the Ebola virus
U.S. government researchers working to find ways to treat the highly deadly Ebola virus said on Sunday a new approach from AVI BioPharma Inc saved monkeys after they were infected.

Two experimental treatments protected more than 60 percent of monkeys infected with Ebola and all the monkeys infected with a related virus called Marburg, the team at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick, Maryland reported.

AVI BioPharma already has a contract worth up to $291 million from the U.S. Department of Defense to develop Ebola treatments.

Writing in the journal Nature Medicine, Sina Bavari and colleagues said the drugs tested are antisense phosphorodiamidate morpholino oligomers, or PMOs, called AVI-6002 and AVI-6003.

"Taken together, these studies provide a major advancement in therapeutic development efforts for treatment of filovirus hemorrhagic fever," Bavari's team wrote.

Full story here.

No comments: